Comparison of Bran-Processed and Crude Atractylodes Lancea Effects on Spleen Deficiency Syndrome in Rats
Dong-Hua Xue1, Yu-Qiang Liu2, Qian Cai2★, Ke Liang2, Bing-Yuan Zheng2, Fang-Xiao Li2, Xue Pang2★ Corresponding author
- 1School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian 116600, China.
- 2Benxi Institute of Traditional Chinese Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang 110000, China.
CORRESPONDENCE
Qian Cai
Benxi Institute of Traditional Chinese Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang 110000, China.
Received: 29-03-2017; Revised: 03-05-2017; Accepted: 03-05-2017.
Volume 14, Issue 54 · pp. 214–219 · PUBLISHED 10 April 2018 · DOI: 10.4103/pm.pm_126_17
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: The rhizome of Atractylodes lancea (AL) is usually used for the treatment of various diseases such as spleen deficiency syndrome (SDS). Both bran‑processed and crude AL is included in Chinese Pharmacopoeia. The different efficacies of bran‑processed and crude AL on SDS are largely unknown, and the mechanisms of AL effects have not been fully elucidated. Objective: The objective of the study was to compare the effects of bran‑processed and crude AL and then assess the mechanisms of treating SDS. Materials and Methods: The model of SDS in rats was established using excessive exertion, combined with an irregular diet and intragastric administration of the extract of Sennae Folium, and different doses of bran‑processed and crude AL were gavaged. The serum was analyzed by an enzyme‑linked immunosorbent assay (ELISA), and small intestinal tissues were analyzed by reverse transcription‑polymerase chain reaction (RT‑PCR). Results: The injury of SDS was alleviated by the treatment of bran‑processed and crude AL. Compared to model group, the indexes of trypsin (TRY), amylase (AMS), vasoactive intestinal peptide (VIP), somatostatin (SS), gastrin (GAS), substance P (SP), Na+‑K+‑ATPase, and succinic dehydrogenase in serum of each administration group were increased by ELISA, and the mRNA expressions of VIP, SS, GAS, and SP in small intestinal tissues were increased by RT‑PCR. Furthermore, in a dose‑dependent manner, the bran‑processed and crude AL increased the levels of TRY, AMS, VIP, and GAS and the mRNA expression levels of VIP. Compared with the crude AL, the bran‑processed AL was more effective in treating SDS. Conclusion: Through the mechanisms of treating SDS by AL, both bran‑processed and crude AL has alleviated the symptoms of SDS.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Xue, D., Liu, Y., Cai, Q., Liang, K., Zheng, B., Li, F., & Pang, X. (2018). Comparison of Bran-Processed and Crude Atractylodes Lancea Effects on Spleen Deficiency Syndrome in Rats. Pharmacognosy Magazine, 14(54), 214–219. https://doi.org/10.4103/pm.pm_126_17